Swiss Agency Firms Up Role In Multi-Country Drug Review Scheme

New Guidance Explains Workings Of Project Orbis

 
• By Ian Schofield

Experience gained from pilot participation has convinced the Swiss medicines agency that the collaborative cancer drug review initiative is the way forward.

Coordination, knowledge sharing.
Key regulators are taking part in a collaborative review initiative coordinated by the US FDA • Source: Shutterstock

More from International

More from Geography